Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Schedule of Potentially Dilutive Instruments (Details)

v3.21.1
Net Loss Per Share - Schedule of Potentially Dilutive Instruments (Details) - shares
shares in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of anti-dilutive shares (in shares) 121,225 31,436
Series A Preferred stock    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of anti-dilutive shares (in shares) 118,805 28,722
Warrants    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of anti-dilutive shares (in shares) 2,067 2,067
Unvested restricted stock units    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of anti-dilutive shares (in shares) 159 420
Stock options    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Number of anti-dilutive shares (in shares) 194 227